Litera Microsystems has announced Catalyst Biosciences, a biopharmaceutical company headquartered in San Francisco, CA, has recently chosen to implement DocXtools, Content Companion, and Change-Pro Premier. The company will roll out the solution to its writers, accelerating the creation, review, comparison, and formatting of their documents.
Matt Miller, Litera Microsystems Director of Life Sciences Products, said, “Catalyst Biosciences, a biopharmaceutical company committed to developing valuable therapies for patients with hemophilia, has chosen to leverage our products to reduce time spent creating, reviewing, and finalizing documents. We’re excited to work with their team as they continue to invest in developing novel medicines to address serious medical conditions for patients.”
About Litera Microsystems
Litera Microsystems is the leading provider of software for drafting, proofreading, comparing, repairing, cleaning and securing documents in the legal and life sciences industries worldwide. Our core products empower users to generate, review, and distribute high-quality content quickly and securely, from any device. Today, Litera Microsystems supports thousands of document-intensive organizations across the globe, helping them satisfy the complex demands of clients and regulators.